| Record ID | marc_columbia/Columbia-extract-20221130-012.mrc:104155474:3651 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-012.mrc:104155474:3651?format=raw |
LEADER: 03651pam a22004814a 4500
001 5611919
005 20221121193916.0
008 050915t20062006inu b s001 0 eng
010 $a 2005027198
015 $aGBA618655$2bnb
016 7 $a101257289$2DNLM
016 7 $a013391216$2Uk
020 $a0253347483 (cloth : alk. paper)
024 3 $a9780253347480
035 $a(OCoLC)OCM61692698
035 $a(NNC)5611919
035 $a5611919
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dUKM$dC#P$dOrLoB-B
042 $apcc
043 $an-us---
050 00 $aHD9666.5$b.W43 2006
060 10 $aQV 736$bW374p 2006
082 0 $a174/.96151$222
100 1 $aWeber, Leonard J.,$d1942-$0http://id.loc.gov/authorities/names/n86066881
245 10 $aProfits before people? :$bethical standards and the marketing of prescription drugs /$cLeonard J. Weber.
260 $aBloomington :$bIndiana University Press,$c[2006], ©2006.
300 $a206 pages ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aBioethics and the humanities
504 $aIncludes bibliographical references (p. [185]-197) and index.
505 00 $g1.$tEthics and for-profit business -- $g2.$tThe pharmaceutical industry and its stakeholders -- $g3.$tDrug companies and healthcare professionals : the ethics agenda -- $g4.$tMedical professionalism and scientific integrity -- $g5.$tThe industry's code : not good enough -- $g6.$tDrug samples : the most important gifts -- $g7.$tMarketing is not objective education -- $g8.$tMedical education : industry at arm's length -- $g9.$tClinical research and the limits of commercial interests -- $g10.$tCitizens and consumers -- $g11.$tDirect-to-consumer advertising : conflicting interests -- $g12.$tDirect-to-consumer advertising : better is better.
520 1 $a"The pharmaceutical industry and its practices have come under intense criticism in recent years. One poll found that 70 percent of the individuals sampled agreed that drug companies put profits ahead of people. Is this perception accurate? Have drug companies traded ethics for profits and placed people at risk?" "In this book, Leonard J. Weber examines the practices of the pharmaceutical industry that have raised such ethical concerns. Providing systematic ethical analysis and reflection, he discusses such practices as compensating physicians for serving as speakers or consultants, providing incentives to physicians to enroll patients as subjects in clinical research, and advertising prescription drugs to the public through the mass media. Weber's critique of the industry is stern. While acknowledging that new industry guidelines are promising, he finds much room for improvement in the conduct of the drug companies in marketing their products. Yet Weber makes a strong case that profits and ethics are not antithetical."--BOOK JACKET.
650 0 $aPharmaceutical industry$xMoral and ethical aspects$zUnited States.
650 0 $aMarketing$xMoral and ethical aspects$zUnited States.
650 12 $aDrug Industry$xethics.$0https://id.nlm.nih.gov/mesh/D004345Q000941
650 22 $aDrug Industry$xeconomics.$0https://id.nlm.nih.gov/mesh/D004345Q000191
650 22 $aMarketing$xethics.$0https://id.nlm.nih.gov/mesh/D040541Q000941
650 22 $aPharmaceutical Preparations.$0https://id.nlm.nih.gov/mesh/D004364
651 2 $aUnited States.$0https://id.nlm.nih.gov/mesh/D014481
830 0 $aBioethics and the humanities.$0http://id.loc.gov/authorities/names/n2004123810
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/ecip0519/2005027198.html
852 00 $boff,bus$hHD9666.5$i.W43 2006